AMLX Earnings — Amylyx Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
AMLX — Amylyx Pharmaceuticals, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$14.35
Market Cap$1.6B
P/E—
52W Range$4.76 – $18.61
Next Earnings2026-08-06
About Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
